Kate Hagan reports:
One of the world’s biggest drug companies has been accused of paying Australian pharmacists to promote some of its best-selling drugs, in a controversial deal that has divided the profession.
Pfizer pays pharmacies a $7 ”administration fee” for each patient signed up to so-called support programs that involve the drug company providing information directly to patients about nine of its drugs.
[…]
Pfizer receives patient information, including mobile phone numbers and email addresses, as part of the scheme, under which it provides regular information to patients about their condition and medication.
Like the Blackmores deal, when one of nine Pfizer drugs is being dispensed, the guild’s computer system prompts pharmacists that patients are eligible for a support program.
Read more on The Advocate.
h/t, @PrivacyProf, via @Clarinette02